Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Big moves in Washington are raising flags for child neurologists. President Trump signed an executive order overhauling childhood vaccine recommendations, and HHS is seeking public input on how vaccines are recommended and shared with clinicians. Meanwhile, the Senate passed a stopgap funding bill, keeping federal operations running only through December 11.
Washington's August agenda packed a punch for the child neurology community. President Trump signed an executive order introducing revised "Gold Standard Childhood Vaccine Recommendations," while HHS launched a Request for Information on federal vaccine recommendation categories and shared clinical decision-making. Together, these moves could reshape how vaccination decisions are made — particularly for children who need individualized clinical assessments, a group central to child neurology practice.
On the funding front, the Senate approved a continuing resolution to keep federal operations going through December 11, but FY 2027 appropriations and a packed legislative to-do list still loom large. The compressed fall calendar means healthcare stakeholders will need to stay alert.
The Child Neurology Society (CNS) is actively monitoring several related developments, including CDC leadership changes, ACIP activity, immunization guidance updates, and the ongoing measles outbreak.
Key Takeaways:
Why it matters: Changes to vaccine recommendation frameworks could directly impact how child neurologists counsel families and make clinical decisions for vulnerable pediatric patients — making these policy shifts far more than a Washington inside-baseball story.
